These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 454514)

  • 21. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
    Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
    J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypolipidaemic aryloxyacetic acids.
    Schacht E
    Top Curr Chem; 1977; 72():99-123. PubMed ID: 339406
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients].
    Marini U; Bargiggia A; Riboli P
    Farmaco Prat; 1981 Dec; 36(12):532-41. PubMed ID: 7319020
    [No Abstract]   [Full Text] [Related]  

  • 26. [The action of a fibric acid derivative on lipid metabolism].
    Filip M; Păduraru I; Nechifor M; Dănilă GH; Popovici I; Filip FM; Poşircă F
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):573-6. PubMed ID: 2636755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats.
    Cayen MN; Dvornik D
    Atherosclerosis; 1978 Mar; 29(3):317-27. PubMed ID: 208586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model.
    Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK
    Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
    Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR
    Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clofibrate treatment of hyperlipidemia in chronic renal failure.
    di Giulio S; Boulu R; Drüeke T; Nicolaĭ A; Zingraff J; Crosnier J
    Clin Nephrol; 1977 Dec; 8(6):504-9. PubMed ID: 598055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of clofibrate and its derivative methyl clofenapate.
    Craig GM
    Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood.
    Lupp A; Karge E; Danz M; Deufel T; Oelschläger H; Klinger W
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):203-18. PubMed ID: 16250258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypolipidemic and antioxidant activity of ethanolic extract of Symplocos racemosa Roxb. in hyperlipidemic rats: an evidence of participation of oxidative stress in hyperlipidemia.
    Durkar AM; Patil RR; Naik SR
    Indian J Exp Biol; 2014 Jan; 52(1):36-45. PubMed ID: 24617014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.